Abstract
Objective. To evaluate the impact of severe obstructive sleep apnea syndrome (OSAS) on cognitive function and the severity of anxiety-depressive symptoms in patients with moderate vascular cognitive disorder (VCD), and identify the most susceptible cognitive domains. Material and methods. Fifty-one patients with moderate VCD were examined. The main group consisted of patients with moderate VCD and severe OSAS (n=26, AHI≥30), compared to patients with moderate VCD but without OSAS (n=25, AHI<5). Cardiorespiratory monitoring was used to diagnose OSAS. Neuropsychological testing included the Montreal Cognitive Assessment Scale (MoCA); the Beck Depression Inventory (BDI), which includes the cognitive-affective subscale (BDI (C-A)), the somatic symptoms of depression subscale (BDI (S-P)) and the total score (BDI, total score); the State-Trait Anxiety Inventory (STAI), which includes trait (STAI-T) and state anxiety (STAI-S); the Frontal Assessment Battery (FAB); the FCSRT-IR (Free and Cued Selective Reminding Test — Immediate Recall), which includes an assessment of free recall (FCSRT-IR, FR), playback with prompt (FCSRT-IR, CR), total score (FCSRT-IR, total score) and Index of Sensitivity of Cueing; Symbol Digit Modalities Test (SDMT). Results. In the main group, lower scores were observed on the FAB (p=0.043), SDMT (p<0.001), FCSRT-IR (total score) (p=0.002), and MoCA (p=0.001) scales, indicating more pronounced cognitive impairment. There were higher rates of depressive symptoms in BDI (total score) (p=0.001), BDI (S-P) (p<0.001), but a low level of anxiety in STAI-S (p=0.001). Conclusion. Severe OSAS in patients with moderate VCD is associated with more severe impairment of executive functions, processing speed, psychomotor reactions, and increased levels of depressive symptoms with low levels of anxiety.
Affiliated Institutions
Related Publications
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder
In this 8-week double-blind multicenter trial, we evaluated the efficacy and safety of 2 fixed doses of agomelatine in patients with moderate to severe major depressive disorder...
Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample
The Hospital Anxiety and Depression Scale (HAD) was evaluated in a Swedish population sample. The purpose of the study was to compare the HAD with the Beck Depression Inventory ...
Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?
Objective We examined cognitive function in older hospitalised patients with chronic atrial fibrillation (AF). Design A prospective substudy of a multicentre randomised trial of...
Relationship of Anxiety and Depression with Respiratory Symptoms: Comparison between Depressed and Non-Depressed Smokers in Singapore
The rising prevalence of smokers in the community, specifically psychiatric patients, necessitates smoking cessation as an important strategy for reducing the harmful effects of...
Exploring the association between childhood and adolescent obesity and depression: a meta‐analysis
Summary This meta‐analysis aimed to evaluate the association between childhood and adolescent obesity and depression. We systematically searched PubMed, PsycInfo, EMBASE and Sci...
Publication Info
- Year
- 2025
- Type
- article
- Volume
- 125
- Issue
- 11
- Pages
- 151-151
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.17116/jnevro2025125111151